Vistapath Expands Clinical Footprint with Deployment of the Sentinel Platform at Freedom Pathology Laboratories in Savannah, Georgia

Vistapath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, announces the successful deployment of the Vistapath Sentinel at Freedom Pathology Laboratories in Savannah, Georgia. The installation marks another milestone in modernizing anatomic pathology through automation and computer vision.  

The Sentinel, the world’s first automated tissue grossing platform, streamlines the process of receiving, assessing, and documenting tissue samples. By leveraging AI and computer vision, the Sentinel generates high-quality gross reports faster and more accurately than traditional methods, while improving safety and traceability across the workflow.  

At Freedom Pathology, the Sentinel has already demonstrated meaningful impact – enhancing throughput, reducing errors, and improving consistency in specimen handling. Its intuitive design was evident from day one, enabling Dr. Todd Bruker’s recently graduated daughter, a lab technician with some prior grossing experience, to operate the Sentinel confidently and efficiently with minimal onboarding, underscoring how accessible the system is even for users without extensive training. 

“Freedom Pathology has been an exceptional partner, and working with the Bruker team reaffirmed why we build the Sentinel the way we do. Their willingness to innovate and their commitment to quality made this deployment seamless, and it’s rewarding to see the Sentinel immediately elevate efficiency and consistency in a real-world lab environment. Our success with Freedom Pathology not only shows the strength of our technology, but how rapidly our company is scaling to support leading pathology practices.” – Timothy Spong, CEO, Vistapath 

“The efficiency of our grossing process is greatly enhanced. We feel that we have joined a strong team and taken a better modern approach to Pathology.” – Dr. Charles Bruker, President, Freedom Pathology LLC 

The collaboration highlights Vistapath’s continued momentum in enabling community and specialty pathology labs to adopt AI-driven automation, regardless of size or existing infrastructure. Freedom Pathology leads a growing network of laboratories nationwide that are leveraging the Sentinel to deliver faster, safer, and more cost-effective diagnostic workflows. 

About Vistapath
VistaPath is modernizing pathology labs using computer vision and artificial intelligence. They provide clients with significant quality, workflow, and strategic benefits with the overall goal of delivering improved results for pathologists, clinicians, and patients. The Sentinel is the company’s first product. Learn more at vistapathbio.com.

Modernizing pathology labs by delivering higher quality, efficiency, and consistency across critical lab processes

1166 Massachusetts Avenue
Cambridge, MA 02139
info@vistapath.ai